CRL analyst estimates
Charles River (CRL) analyst ratings, the average price target and its range, and every firm's latest call.
CRL analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 12, 2026 | Morgan Stanley | Charles River price target raised to $340 from $300 at Morgan Stanley | $340.00 |
| Sep 30, 2026 | UBS | UBS Resumes Charles River Labs (CRL) at Buy | $357.00 |
| Sep 28, 2026 | Jefferies | Charles River Labs (CRL) PT Raised to $340 at Jefferies | $340.00 |
| Sep 25, 2026 | Barclays | Charles River price target raised to $330 from $300 at Barclays | $330.00 |
| Sep 25, 2026 | Mizuho Securities | Charles River Labs (CRL) PT Raised to $295 at Mizuho | $295.00 |
| Sep 25, 2026 | Robert W. Baird | Charles River price target raised to $334 from $291 at Baird | $334.00 |
| Sep 25, 2026 | Evercore ISI | Charles River price target raised to $330 from $320 at Evercore ISI | $330.00 |
| Sep 25, 2026 | RBC Capital | Charles River price target raised to $322 from $282 at RBC Capital | $322.00 |
| Sep 25, 2026 | Deutsche Bank | Charles River price target raised to $320 from $300 at Deutsche Bank | $320.00 |
| Sep 17, 2026 | Argus Research | Charles River price target raised to $330 from $250 at Argus | $330.00 |
| Sep 11, 2026 | Evercore ISI | Charles River price target raised to $320 from $300 at Evercore ISI | $320.00 |
| Aug 10, 2026 | Mizuho Securities | Charles River price target raised to $264 from $230 at Mizuho | $264.00 |
| Aug 10, 2026 | Piper Sandler | Charles River Labs (CRL) PT Raised to $300 at TD Cowen | $300.00 |
| Aug 7, 2026 | Morgan Stanley | Charles River price target raised to $300 from $260 at Morgan Stanley | $300.00 |
| Aug 6, 2026 | Robert W. Baird | Charles River price target raised to $291 from $255 at Baird | $291.00 |
- 13 firms rate CRL: 11 buy, 2 hold, 0 sell.
- The average price target is $327.09 from 11 analysts, from $295.00 to $357.00.
Updated 2026-11-02 17:51 UTC